FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 93 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $54,053,000 | +1046.4% | 1,434,903 | +417.7% | 0.01% | +1200.0% |
Q4 2020 | $4,715,000 | +539.8% | 277,161 | +76.6% | 0.00% | – |
Q3 2020 | $737,000 | -26.9% | 156,899 | -5.0% | 0.00% | – |
Q2 2020 | $1,008,000 | +800.0% | 165,213 | +234.1% | 0.00% | – |
Q1 2020 | $112,000 | -72.0% | 49,446 | -43.2% | 0.00% | – |
Q4 2019 | $400,000 | +20.1% | 87,092 | +1.3% | 0.00% | – |
Q3 2019 | $333,000 | -78.0% | 86,009 | -65.7% | 0.00% | – |
Q2 2019 | $1,514,000 | -12.2% | 251,084 | +95.1% | 0.00% | -100.0% |
Q1 2019 | $1,725,000 | +43.4% | 128,724 | -0.4% | 0.00% | – |
Q4 2018 | $1,203,000 | -56.5% | 129,270 | -35.0% | 0.00% | -100.0% |
Q3 2018 | $2,766,000 | -8.0% | 198,741 | +4.5% | 0.00% | 0.0% |
Q2 2018 | $3,007,000 | -32.7% | 190,172 | -26.9% | 0.00% | 0.0% |
Q1 2018 | $4,469,000 | +11.2% | 260,175 | +41.9% | 0.00% | 0.0% |
Q4 2017 | $4,018,000 | +57.2% | 183,300 | +193.3% | 0.00% | 0.0% |
Q3 2017 | $2,556,000 | -58.9% | 62,490 | -69.8% | 0.00% | -50.0% |
Q2 2017 | $6,221,000 | -20.9% | 206,598 | -5.0% | 0.00% | 0.0% |
Q1 2017 | $7,861,000 | +74.8% | 217,462 | +142.2% | 0.00% | +100.0% |
Q4 2016 | $4,498,000 | -86.9% | 89,769 | -86.3% | 0.00% | -90.0% |
Q3 2016 | $34,347,000 | +296.2% | 654,352 | +212.1% | 0.01% | +400.0% |
Q2 2016 | $8,669,000 | -1.6% | 209,641 | -3.3% | 0.00% | -33.3% |
Q1 2016 | $8,812,000 | +18.1% | 216,860 | +20.6% | 0.00% | +50.0% |
Q4 2015 | $7,464,000 | +1207.2% | 179,838 | +384.5% | 0.00% | – |
Q3 2015 | $571,000 | -47.4% | 37,119 | -15.1% | 0.00% | – |
Q2 2015 | $1,085,000 | +136.4% | 43,699 | +117.7% | 0.00% | – |
Q1 2015 | $459,000 | +61.6% | 20,069 | +90.8% | 0.00% | – |
Q4 2014 | $284,000 | -94.9% | 10,520 | -97.8% | 0.00% | -100.0% |
Q3 2014 | $5,564,000 | -29.4% | 474,372 | -6.4% | 0.00% | 0.0% |
Q2 2014 | $7,881,000 | -20.4% | 506,789 | +0.7% | 0.00% | -33.3% |
Q1 2014 | $9,895,000 | +23.0% | 503,292 | +5.1% | 0.00% | 0.0% |
Q4 2013 | $8,042,000 | – | 478,966 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 1,092,152 | $16,808,219,000 | 9.64% |
GREAT POINT PARTNERS LLC | 1,226,785 | $18,880,000 | 7.47% |
Ghost Tree Capital, LLC | 500,000 | $7,695,000 | 3.46% |
RTW INVESTMENTS, LP | 713,954 | $10,988,000 | 3.41% |
ARMISTICE CAPITAL, LLC | 506,000 | $7,787,000 | 2.66% |
EcoR1 Capital, LLC | 149,000 | $2,293,000 | 1.04% |
Eventide Asset Management | 1,164,900 | $17,928,000 | 1.04% |
Telemetry Investments, L.L.C. | 102,500 | $1,577,000 | 0.68% |
J. Goldman & Co LP | 313,527 | $4,825,000 | 0.41% |
AWM Investment Company, Inc. | 118,199 | $1,819,000 | 0.35% |